InMode (INMD) EPS (Weighted Average and Diluted) (2018 - 2026)
InMode's (INMD) quarterly EPS (Weighted Average and Diluted) came in at $46.2 million in Q1 2026, down 21.23% year-on-year from $58.7 million in Q1 2025, and up 8511710257.21% quarter-over-quarter from $0.54 in Q4 2025.
InMode (INMD) EPS (Weighted Average and Diluted) (2018 - 2026) Analysis & Trends
InMode has disclosed EPS (Weighted Average and Diluted) across 9 years of filings, most recently posting $46.2 million for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at $46.2 million, down 21.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $46.2 million (down 21.23% YoY), and the FY2025 annual result was $1.43, down 36.44% from the prior year.
- EPS (Weighted Average and Diluted) came in at $46.2 million for Q1 2026 at InMode, up from $0.54 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $77.9 million in Q1 2023 to a low of -$8.2 million in Q4 2024.
- The 5-year median for EPS (Weighted Average and Diluted) is $44.9 million (2022), against an average of $39.6 million.
- Across the five-year window, EPS (Weighted Average and Diluted) fell 27.91% in 2022 and surged 100.0% in 2025, its largest moves.
- InMode's EPS (Weighted Average and Diluted) stood at $0.44 in 2022, then jumped by 17642029726.21% to $77.9 million in 2023, then sank by 110.47% to -$8.2 million in 2024, then soared by 100.0% to $0.54 in 2025, then jumped by 8511710257.21% to $46.2 million in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at $46.2 million (Q1 2026), $0.54 (Q4 2025), and $34.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | InMode | 3.35 | -388.37 Mn | 61.55 Mn | 46.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.25 Mn |
| Dec 31, 2025 | 0.54 |
| Jun 30, 2025 | 34.73 Mn |
| Mar 31, 2025 | 58.71 Mn |
| Dec 31, 2024 | -8.16 Mn |
| Mar 31, 2024 | 74.05 Mn |
| Mar 31, 2023 | 77.89 Mn |
| Dec 31, 2022 | 0.44 |
| Sep 30, 2022 | 29.57 Mn |
| Jun 30, 2022 | 44.95 Mn |
| Mar 31, 2022 | 77.44 Mn |
| Dec 31, 2021 | 0.61 |
| Sep 30, 2021 | 31.71 Mn |
| Jun 30, 2021 | 48.15 Mn |
| Mar 31, 2021 | 78.66 Mn |
| Dec 31, 2020 | 0.43 |
| Sep 30, 2020 | 20.41 Mn |
| Jun 30, 2020 | 15.89 Mn |
| Mar 31, 2020 | 21.64 Mn |
| Dec 31, 2019 | 0.25 |